DealMironid, a Glasgow, Scotland-based rare kidney disease treatment developer, raised £34 million in a Series B fundraising round led by Scottish National Investment Bank with participation from Roche Venture Fund and Epidarex Capital.
More on UK Tech News →
SERIES B
08/16/2026
System, a San Francisco-based vertically integrated peptide platform,...
Encoded Therapeutics, a South San Francisco, CA-based precision genetic...
Ferry Health, a San Francisco-based AI healthcare navigation platform,...
GonGlobal, a Melbourne-based needle-free IVF startup, raised $1.2 million...
Thatch, a San Francisco-based employer health benefits platform, raised...
ReEmerge, Inc., an Edina, MN-based medtech for brain injury, raised $37...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
